Estimate of Aztreonam (AZT) Hydrolyzing Enzymes from Clinically Isolated AZT-Resistant Gram-Negative Bacilli
Masakazu Kouda, Ikuko KUMAGAI, Jun’ichi Kobayashi, Ryoko Sugai, Hiroko Matsuzaki, Rintaro NAKAYA
Abstract
Open-access reader
Masakazu Kouda, Ikuko KUMAGAI, Jun’ichi Kobayashi, Ryoko Sugai, Hiroko Matsuzaki, Rintaro NAKAYA
Abstract
Open-access reader
The MICs of Aztreonam (AZT) against 590 clinical isolates of Gram-negative bacilli were determined. About 13.4% (79 strains) of the isolates were AZT-resistant (MIC; 12.5 micrograms/ml less than or equal to). The resistance pattern against various beta-lactams and the effects on MICs of combination of Clavulanic acid (CVA) and AZT against AZT resistant strains suggested that AZT was inactivated by either type of IV (K1), Va (OXA1), or PSE2 beta-lactamases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The MICs of Aztreonam (AZT) against 590 clinical isolates of Gram-negative bacilli were determined. About 13.4% (79 strains) of the isolates were AZT-resistant (MIC; 12.5 micrograms/ml less than or equal to). The resistance pattern against various beta-lactams and the effects on MICs of combination of Clavulanic acid (CVA) and AZT against AZT resistant strains suggested that AZT was inactivated by either type of IV (K1), Va (OXA1), or PSE2 beta-lactamases.
Key concepts: Aztreonam, Bacilli, Microbiology, Gram, Biology, Drug resistance, Bacteria, Enzyme